Further analysis shows that leukemia cells from the ALL patients whose CpG2 exhibits a methylation level greater than Grade I (which was defined as hypermethylation in this study) correlates with significantly reduced GGH mRNA expression (1.3533±1.7306, t = 3.250, P = 0.006). Here, GGH is linked to leukemia.